Class Actions Increasingly Targeting Cannabis Companies

by Julie Hussey, Barak Cohen, Tommy Tobin Recent years have seen increased growth for cannabis companies, especially as the market for THC products continues to expand. But this growth brings with it increasing scrutiny of the industry by regulators and…

Will the FTC Adopt Less Stringent Substantiation Requirements for CBD Claims?

by Natalie Bougenies, Attorney at Harris Bricken If you follow our blog, you know we keep a close eye on enforcement actions taken by the Food and Drug Administration (the FDA) and the Federal Trade Commission (the FTC or the…

FTC Announces Crackdown on Deceptively Marketed CBD Products

December 18, 2020
Press Release
Federal
0 Comments

PRESS RELEASE Companies made unsupported claims that their oils, balms, gummies, coffee, and other goods could treat serious diseases such as cancer and diabetes The Federal Trade Commission today announced the first law enforcement crackdown on deceptive claims in the…

Federal Antitrust Scrutiny and (Certain) Cannabis Deal

By Hilary Bricken, Co-Founder Harris Bricken If you follow state-by-state legal cannabis legalization, you’re aware that despite the federal illegality of cannabis, certain federal agencies police the cannabis industry like they do any other legal industry. For example, the NLRB…

VDACS Okays Manufacture of CBD Products Intended for Human Consumption

The Virginia Department of Agriculture and Consumer Services (“VDACS”) Commissioner Jewel Bronaugh sent a letter (the “July Letter”) to all Virginia-registered Industrial Hemp Processors (“Processors”) on July 15, 2019 notifying the Processors that Governor Northam’s office has directed VDACS to…

FDA Updates Guidance for CBD Products amid a New Round of Warning Letters and Announcement of Date for Public Hearing

By Ian Stewart & Neil Willner Attorneys at Wilson Elser On April 2, 2019, the U.S. Food and Drug Administration (FDA) issued a sweeping press release from outgoing Commissioner Scott Gottlieb covering new steps to advance the agency’s continued evaluation…